BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 26, 2021
View Archived Issues
Patient recruitment ongoing in phase I study of CAR.B7-H3 T-cell therapy in ovarian cancer
Read More
Intra-Cellular plans to develop ITI-1284 for dementia and depressive disorders in the elderly
Read More
REGN-3048 plus REGN-3051 show promise for treatment or prophylaxis of MERS-CoV infection
Read More
Targeting of neoplastic progenitors as new therapeutic strategy in AML
Read More
Xencor and UCLA collaborate to develop novel therapeutic antibodies
Read More
Data from proof-of-concept OSCAR study of otilimab in hospitalized patients with COVID-19
Read More
Promising first cohort data from phase II/III study of DSTAT in severe COVID-19
Read More
Altimmune initiates enrollment in phase I study of AdCOVID intranasal COVID-19 vaccine candidate
Read More
ESSA Pharma and Astellas collaborate to investigate EPI-7386 plus enzalutamide in mCRPC
Read More
Initiation of phase IIa study evaluating BGE-117 in elderly with unexplained anemia
Read More
Repure Life Science patents p300 inhibitors
Read More
Well Marker Bio presents new MST1R inhibitors
Read More
Gene variants can increase fat, decrease cardiometabolic risk
Read More
Janssen Pharmaceutica synthesizes new compounds for HBV infection
Read More
First patient dosed in phase III study of eftansomatropin alfa in China
Read More
Amgen discovers new KIF18A inhibitors
Read More
Italian researchers present new PTPN11 inhibitors
Read More
MicroRNA switch therapy self-assembles into nanoparticles to treat atherosclerosis
Read More
Compugen presents updated results from phase I study of COM-701
Read More
Chromosome organization machinery linked to DNA repair
Read More
First patient dosed in phase I/II study of KB-0742
Read More
Targeting EPIC1-EZH2 axis as potential new immunotherapy strategy in cancer
Read More
Pilot trial of lentivirus-mediated enzyme gene therapy for the treatment of Fabry disease
Read More
FDA grants accelerated approval to Amondys 45 for Duchenne muscular dystrophy
Read More
IDMC recommends stopping enrollment of placebo group in phase III outpatient trial of REGEN-COV
Read More
Aivita completes phase I study of AV-COVID-19
Read More
SARPAC study of inhaled sargramostim in COVID-19 meets primary endpoint
Read More
NIAID to conduct phase I study of mRNA-1273.351 for SARS-CoV-2 variant B.1.351
Read More